Side-by-side comparison of AI visibility scores, market position, and capabilities
Analog Devices (ADI) reported $9.4B revenue in FY2024, down 23% YoY (inventory correction). World's #2 analog chip maker. Leader in high-performance signal processing. HQ: Wilmington, MA.
Analog Devices, Inc. is a global leader in high-performance analog, mixed-signal, and digital signal processing (DSP) integrated circuits, headquartered in Wilmington, Massachusetts. Founded in 1965, ADI merged with Linear Technology (2017) and Maxim Integrated (2021) to become the world's second-largest analog semiconductor company behind Texas Instruments. The company reported revenues of $9.4B in fiscal year 2024 (ending October 2024), down approximately 23% year-over-year due to a severe inventory correction in industrial and automotive markets.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.